Tranexamic acid, a new antifibrinolytic agent
Kjellman, H.; Schannong, M.
Nordisk Medicin 83(6): 166-168
1970
ISSN/ISBN: 0029-1420 PMID: 4910677 Document Number: 22169
Document emailed within 1 workday
Related Documents
Marmo, E.; Ungaro, B.; Giordano, L. 1971: On the cardiovascular effects of some antifibrinolytic drugs (Trasylol, epsilon-aminocaproic acid, tranexamic acid) Minerva Cardioangiologica 19(2): 86-115Storm, O. 1975: Tranexamic acid (Cyclocapron, Kabi). An antifibrinolytic Ugeskrift for Laeger 137(20): 1120-1121
Waly, N.G. 1995: Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions Egyptian Dental Journal 41(1): 961-968
Gultekin, M.; Diribaş, K.; Buru, E.; Gökçeoğlu, M.A. 2009: Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding Clinical and Experimental Obstetrics and Gynecology 36(3): 163-165
Davidoff, S.M. 1970: Experience with the antifibrinolytic agent Pamba in maxillofacial surgery Deutsche Stomatologie 20(5): 391-393
Lemgruber, I.; Maywald, V. 1970: Use of Transamine, new antifibrinolytic agent. Its use in gynecology, obstetrics and surgery Hospital (Rio de Janeiro) 77(1): 107-118
Nishimatsu, T.; Shibasaki, T.; Sasaki, H.; Nukui, H.; Kawafuchi, J.; Okada, K. 1980: Rapid measurement of fibrinolytic activity in CSF by t-AMCA score method. Correlation with concentration of antifibrinolytic agent in CSF Rinsho Byori. Japanese Journal of Clinical Pathology 28(3): 265-270
Maineri, P.; Covaia, G.; Realini, M.; Caccia, G.; Ucussich, E.; Luraschi, M.; Crosta, A.; Foresti, B.; Chiaranda, M. 2000: Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid Minerva Cardioangiologica 48(6): 155-160
Desai, S.; Ayres, E.; Bak, H.; Manco, M.; Lynch, S.; Raab, S.; Du, A.; Green, D.; Skobowiat, C.; Wangari-Talbot, J.; Zheng, Q. 2019: Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: a Clinical Evaluation Journal of Drugs in Dermatology: Jdd 18(5): 454-459
Godal, H.C. 1991: Rational use of tranexamic acid Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(18): 2274-2275
Gram, Jørgen. 2009: Tranexamic acid and dentoalveolar surgery Ugeskrift for Laeger 171(21): 1801; Author Reply 1801
Gårskjaer, F.; Nepper-Rasmussen, Jørgen. 2006: Tranexamic acid and subarachnoid hemorrhage Ugeskrift for Laeger 168(18): 1777; Author Reply 1777
Tscheikuna, J.; Chvaychoo, B.; Naruman, C.; Maranetra, N. 2002: Tranexamic acid in patients with hemoptysis Journal of the Medical Association of Thailand 85(4): 399-404
Ali, I.M.; Landymore, R.W. 1994: The use of tranexamic acid in cardiac operations Journal of Thoracic and Cardiovascular Surgery 107(5): 1377
Srinil, S.; Jaisamrarn, U. 2005: Treatment of idiopathic menorrhagia with tranexamic acid Journal of the Medical Association of Thailand 88(Suppl 2): S1-S6
Hoste, S.; Van Aken, H.; Stevens, E. 1991: Tranexamic acid in the treatment of anaphylactic shock Acta Anaesthesiologica Belgica 42(2): 113-116
Humbert, P.; Gutknecht, J.; Mallet, H.; Dupond, J.L.; Leconte des Floris, R. 1987: Tranexamic acid and thrombosis of the superior longitudinal sinus Therapie 42(1): 65-66
Sundbeck, A.; Alpsten, M.; Appelgren, L.; Karlsson, L.; Månsson, L.G.; Peterson, H.I. 1981: Influence of tranexamic acid on tumour blood flow Anticancer Research 1(3): 141-148
Dussel, J.N.; Zdankiewicz, P. 2015: Tranexamic acid: familiarity and use in the Level Ii trauma hospital American Surgeon 81(1): E10-E11
Jericó-Pascual, I.; Gállego-Cullere, J. 2008: Stroke, tranexamic acid and patent foramen ovale Revista de Neurologia 46(3): 186